 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies Company NYSE: SQZ, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it will present new preclinical findings on the companys enhanced antigen presenting cell eAPC platform at the American Association for Cancer Research AACR Annual Meeting on April 8-13, 2022 in New Orleans, Louisiana. The new eAPC work demonstrates the companys Cell Squeeze platforms ability to deliver 